Daniell Richard sold 20,003 shares of TEVA PHARMACEUTICAL INDUSTRIES LTD at $42.80 for −$856k on Nov 11, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
EVP, Europe Commercial
EVP, Europe Commercial
Filed Nov 12, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$856,154.40Shares × reported price
Shares traded
20,003Ordinary Shares
Price per share
$42.80Reported price. Read footnotes for ranges.
% of reported position traded
26.4%This security and ownership context
Holdings after
55,755Direct
Trade date
Nov 11, 2026Sell
Filed
Nov 12, 2026, 4:15 PM ET1-day reporting delay
Accession
0001193125-26-458451Code S · Transaction 398870
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 75,758 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 9, 2026Option exercise25,000$0.00$0Trade 398871
Nov 11, 2026Option exercise20,003$0.00$0Trade 398872
Nov 9, 2026Sell25,000$42.91−$1,072,790Trade 398868
Nov 9, 2026Option exercise25,000$34.70$867,500Trade 398867
Nov 11, 2026Option exercise20,003$34.70$694,104.10Trade 398869
6 transaction rows in this filing. Joint filers share the same rows.

TEVA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
TEVA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −5.7%1w ago −7%1d ago −2.9%
Returns since7d30d90d180d1y

Footnotes in full

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.90 to $42.99, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.78 to $42.85, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. F3: Stock options were granted on March 3, 2017, with 11,250 vested on each of March 3, 2018, March 3, 2019 and March 3, 2020, and 11,253 vested on March 3, 2021.